8A-PDHQ

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Template:Short description Template:Cs1 config Template:Drugbox

8a-Phenyldecahydroquinoline (8A-PDHQ) is a high affinity NMDA antagonist developed by a team at Parke Davis in the 1950s.[1] It is a structural analog of phencyclidine with slightly lower binding affinity than the parent compound. (−)-8a-Phenyldecahydroquinoline has an in vivo potency comparable to that of (+)-MK-801.[2][3]

References

<templatestyles src="Reflist/styles.css" />

  1. US Patent 3035059
  2. Script error: No such module "Citation/CS1".
  3. Script error: No such module "Citation/CS1".

Script error: No such module "Check for unknown parameters".

Script error: No such module "Navbox". Template:Ionotropic glutamate receptor modulators


Template:Asbox